Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 28 July 2009, doi:10.1136/bmj.b3041
Cite this as: BMJ 2009;339:b3041
| The first 150 words of the full text of this article appear below. |
Godlee ably manages a difficult editorial balancing act by recognising that occasionally less is more.1 Medicalisation can be bad for your health, as "screening for abdominal aortic aneurysm seems to be effective" hints. I agree with Heaths informed decision to say no to breast screening.2 Should I have screening for abdominal aortic aneurysm?
Buxtons pertinent editorial discusses cost effective modelling.3 "A 42% relative risk reduction in mortality related to abdominal aortic aneurysm (absolute risk reduction from 0.33% to 0.19%)" sounds impressive. But how many were harmed, died, or were falsely reassured? "There may be a small increase in net deaths in the short term" is worrying.
Editors should require the statement of benefits and harms in absolute terms. Thompson and colleagues state: "We used unadjusted Cox regression to compare deaths related to abdominal aortic aneurysm (censoring other causes of death) and all cause mortality."4 The crucial data in table 1
L Sam Lewis, general practitioner1
1 Surgery, Newport, Pembrokeshire SA42 0TJ
sam@garthnewydd.freeserve.co.uk